조현병 동물모델 및 이의 제조방법

    公开(公告)号:KR102217401B1

    公开(公告)日:2021-02-22

    申请号:KR1020200087421

    申请日:2020-07-15

    Abstract: 본발명은내측고삐핵의콜린성신경세포에서특이적으로 ANO1(Anoctamin 1) 유전자가결손된생쥐인것을특징으로하는조현병동물모델및 이의제조방법등에관한것이다. 본발명에따른조현병동물모델은조현병발병기전에주요하게작용하는뇌조직인내측고삐핵을표적으로한 것으로서, 내측고삐핵의콜린성신경세포에서 ANO1 유전자가특이적으로결손되는경우조현병의양성증상, 음성증상, 및인지증상이나타남을확인하여조현병이유발됨을확인하였는바, 본발명의동물모델이조현병의발병기전연구, 치료제개발및 스크리닝의동물모델로유용하게이용될것으로기대된다.

    망막의 ON/OFF 이극세포 선택적 유전자 발현 방법
    3.
    发明授权
    망막의 ON/OFF 이극세포 선택적 유전자 발현 방법 有权
    在视网膜ON / OFF双极细胞中选择性基因表达的方法

    公开(公告)号:KR101594421B1

    公开(公告)日:2016-02-18

    申请号:KR1020130091597

    申请日:2013-08-01

    Abstract: 본발병은망막에존재하는 ON 또는 OFF 이극세포에선택적으로광유전자를발현시키기위한방법으로, 구체적으로는 ON 이극세포에특이적으로발현하는프로모터, 제1 표적유전자및 Cre 유전자를포함하는제1 벡터및 ON/OFF 이극세포에발현하는프로모터, 제2 표적유전자및 loxP 서열을포함하는제2 벡터를포함하는이극세포에서선택적유전자발현용키트및 이를이극세포에도입하여이극세포에서유전자를선택적으로발현시키는방법에관한것이다. 일구체예에서개시된바업을이용할경우광수용체가없을경우에도이극세포에서빛을감지할수 있으며, 이러한경우광수용체가사멸하는안질환을갖는환자에게효과적인치료법을제공할수 있다.

    페녹시프로판올 유도체 및 이를 함유하는 약학적 조성물
    9.
    发明公开
    페녹시프로판올 유도체 및 이를 함유하는 약학적 조성물 有权
    1-苯氧基丙醛和含有其的药物组合物的衍生物

    公开(公告)号:KR1020130103461A

    公开(公告)日:2013-09-23

    申请号:KR1020130092770

    申请日:2013-08-05

    Abstract: PURPOSE: A phenoxypropanol derivative is provided to effectively suppress T-type calcium channel or TWIK-related K+ (TREK)-1 channel, thereby treating various diseases caused by the activation of the channels. CONSTITUTION: A phenoxypropanol derivative of chemical formula I or a racemic body, a pharmaceutically acceptable salt, a solvate, or a hydrate thereof is provided. A pharmaceutical composition for preventing or treating diseases related to T-type calcium channel or TREK-1 channel, selected among Parkinson's disease, Alzheimer's disease, schizophrenia, sleep disorder, epilepsy, pain, hypertension, arrhythmia, ventricular hypertrophy, angina pectoris, heart failure, myocardial infarction, cancer, hypoxia, cerebral ischemia, alkalemia, and depression contains the phenoxypropanol derivative, the racemic body, the pharmaceutically acceptable salt, the solvate, or the hydrate as an active ingredient. A method for suppressing T-type calcium channel or TREK-1 channel comprises the steps of: preparing a biological sample from an organ; and applying the phenoxypropanol derivative, the racemic body, the pharmaceutically acceptable salt, the solvate, or the hydrate to the biological sample.

    Abstract translation: 目的:提供苯氧基丙醇衍生物,有效抑制T型钙通道或TWIK相关K +(TREK)-1通道,从而治疗由通道激活引起的各种疾病。 构成:提供化学式I的苯氧基丙醇衍生物或外消旋体,其药学上可接受的盐,溶剂化物或其水合物。 用于预防或治疗与帕金森病,阿尔茨海默病,精神分裂症,睡眠障碍,癫痫,疼痛,高血压,心律失常,心室肥大,心绞痛,心力衰竭有关的T型钙通道或TREK-1通道相关疾病的药物组合物 ,心肌梗死,癌症,缺氧,脑缺血,碱血症和抑郁症含有苯氧基丙醇衍生物,外消旋体,药学上可接受的盐,溶剂合物或水合物作为活性成分。 抑制T型钙通道或TREK-1通道的方法包括以下步骤:从器官制备生物样品; 以及将所述苯氧基丙醇衍生物,外消旋体,药学上可接受的盐,溶剂合物或水合物施用于生物样品。

    페녹시프로판올 유도체 및 이를 함유하는 약학적 조성물
    10.
    发明公开
    페녹시프로판올 유도체 및 이를 함유하는 약학적 조성물 有权
    1-苯氧基丙醛和含有其的药物组合物的衍生物

    公开(公告)号:KR1020130060799A

    公开(公告)日:2013-06-10

    申请号:KR1020110127053

    申请日:2011-11-30

    Abstract: PURPOSE: A phenoxy propanol derivative is provided to effectively suppress T-type calcium channel or TREK(TWIK-related K+)-1 channel and to treat various diseases. CONSTITUTION: A pharmaceutical composition for preventing or treating diseases related to T-type calcium channel or TREK-1 channel contains a phenoxy propanol derivative with a structure of chemical formula I or a racemic body, a pharmaceutically acceptable salt, solvent, or hydrate thereof as an active ingredient. A method for suppressing the T-type calcium channel or TREK-1 channel comprises: a step of preparing a biological sample from organism; and a step of applying the phenoxy propanol derivative, or a racemic body, a pharmaceutically acceptable salt, solvate, or hydrate thereof.

    Abstract translation: 目的:提供苯氧丙醇衍生物,有效抑制T型钙通道或TREK(TWIK相关K +)-1通道,治疗各种疾病。 构成:用于预防或治疗与T型钙通道或TREK-1通道有关的疾病的药物组合物含有具有化学式I结构的苯氧基丙醇衍生物或其外消旋体,其药学上可接受的盐,溶剂或水合物作为 活性成分。 抑制T型钙通道或TREK-1通道的方法包括:从生物体制备生物样品的步骤; 以及施用苯氧基丙醇衍生物或外消旋体,其药学上可接受的盐,溶剂合物或水合物的步骤。

Patent Agency Ranking